Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amdocs Sees Q3 Adj EPS $1.68-$1.74 vs $1.77 Est; Sees Sales $1.110B-$1.150B vs $1.13B Est

Author: Benzinga Newsdesk | May 07, 2025 03:08pm
Amdocs (NASDAQ:DOX) is looking for Q3 Adj EPS of $1.68-$1.74 vs $1.77 analyst estimate. sees sales of $1.110 billion-$1.150 billion vs $1.13 billion analyst estimate.

Posted In: DOX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist